Clonidine Versus Adenosine to Treat Neuropathic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Pain
Interventions
DRUG

clonidine

Clonidine-a drug commonly used to treat high blood pressure-has been shown to effectively treat neuropathic pain, is FDA-approved for administration via epidural (an injection given in the lower back), and is the third most commonly prescribed drug for chronic intrathecal (an injection into the cerebrospinal fluid) use in people with chronic pain.

DRUG

adenosine

Adenosine-a drug commonly administered intravenously (into a vein) to treat certain types of abnormal heart rhythms-has been found to reduce areas of allodynia (pain caused by a stimulus that does not normally cause pain) after intrathecal, but not intravenous administration in people with neuropathic pain.

DRUG

placebo

inactive substance

DRUG

placebo

inactive substance

Trial Locations (2)

27103

The Center for Clinical Research, 145 Kimel Park Drive, Winston-Salem

27157-1009

Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00349921 - Clonidine Versus Adenosine to Treat Neuropathic Pain | Biotech Hunter | Biotech Hunter